Risk factors for Blastocystis infection in HIV/AIDS patients with highly active antiretroviral therapy in Southwest China

被引：0
|
作者：
Shun-Xian Zhang
Fen-Yan Kang
Jia-Xu Chen
Li-Guang Tian
Lan-Lan Geng
机构：
[1] Guangzhou Medical University,Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center
[2] Guangzhou Medical University,Department of Gastroenterology, Guangzhou Women and Children’s Medical Center
[3] The Gansu Center for Disease Control and Prevention,undefined
[4] National Institute of Parasitic Diseases,undefined
[5] Chinese Center for Disease Control and Prevention,undefined
[6] Key Laboratory for Parasitology and Vector Biology,undefined
[7] MOH of China,undefined
[8] WHO Collaborating Center for Tropical Diseases,undefined
[9] National Center for International Research on Tropical Diseases,undefined
来源：
Infectious Diseases of Poverty | / 8卷
关键词：
HIV/AIDS; Co-infection; Risk factor; Interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Risk factors for Blastocystis infection in HIV/AIDS patients with highly active antiretroviral therapy in Southwest China
    Zhang ShunXian
    Kang FenYan
    Chen JiaXu
    Tian LiGuang
    Geng LanLan
    贫困所致传染病（英文）, 2019, 08 (05) : 83 - 90
  • [2] Risk factors for Blastocystis infection in HIV/AIDS patients with highly active antiretroviral therapy in Southwest China
    Zhang, Shun-Xian
    Kang, Fen-Yan
    Chen, Jia-Xu
    Tian, Li-Guang
    Geng, Lan-Lan
    INFECTIOUS DISEASES OF POVERTY, 2019, 8 (01)
  • [3] Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy
    Jabs, DA
    Holbrook, JT
    Van Natta, ML
    Clark, R
    Jacobson, MA
    Kempen, JH
    Murphy, RL
    OPHTHALMOLOGY, 2005, 112 (05) : 771 - 779
  • [4] Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China
    Wang, Yuan-Yuan
    Jin, Yu
    Chen, Chang
    Zheng, Wei
    Wang, Shi-Bin
    Ungvari, Gabor S.
    Ng, Chee H.
    Zhang, Xiaohua Douglas
    Wang, Gang
    Xiang, Yu-Tao
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (08): : 913 - 922
  • [5] Hepatotoxicity associated with highly active antiretroviral therapy (HAART) in HIV/AIDS patients
    Dragovic, G
    Jevtovic, D
    DRUG SAFETY, 2005, 28 (10) : 951 - 952
  • [6] Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection
    Caso, JAA
    Mingo, CS
    Tena, JG
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16): : 1239 - 1240
  • [7] Highly active antiretroviral therapy: a misnomer in HIV/AIDS terminology
    Philpot, R
    INTERNAL MEDICINE JOURNAL, 2004, 34 (03) : 139 - 139
  • [8] Monitoring of highly active antiretroviral therapy in HIV infection
    Walker, A. Sarah
    Gibb, Diana M.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (01) : 27 - 33
  • [9] Excess Mortality in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy: Temporal Changes and Risk Factors
    Puhan, Milo A.
    Van Natta, Mark L.
    Palella, Frank J.
    Addessi, Adrienne
    Meinert, Curtis
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (08) : 947 - 956
  • [10] Dyslipidemia in AIDS patients on highly active antiretroviral therapy
    Nery, Max Weyler
    Turchi Martelli, Celina Maria
    Turchi, Marilia Dalva
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (02): : 151 - 155
12345